Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Ossenkoppele

Showing results (101-110 of 152) with videos related to

Pageof 16
Sort By:
Leukemia|April 15, 2003
A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemiaA van Stijn, A Kok, M A van der Pol, et al.
The Journal of Pathology|January 10, 2006
Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphomaJ J F Muris, C J L M Meijer, W Vos, et al.
European Journal of Haematology|January 1, 1991
Imipenem-cilastatin for empirical therapy in neutropenic patients with fever: an open study in patients with hematologic malignanciesP C Huijgens, G J Ossenkoppele, T F Weijers, et al.
Blood|December 1, 1994
Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localizationP C de Bruin, J A Kummer, P van der Valk, et al.
Leukemia Research|February 2, 2011
High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2M E D Chamuleau, G J Ossenkoppele, A van Rhenen, et al.
British Journal of Cancer|April 3, 1999
Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitorsS F Thijsen, G J Schuurhuis, J W van Oostveen, et al.
Haematologica|September 18, 2012
Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trialNigel Russell, Kenny Douglas, Anthony D Ho, et al.
Cell Death & Disease|June 27, 2014
IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survivalH Jmp Verhagen, D C de Leeuw, M Gm Roemer, et al.
Leukemia|August 1, 1994
Maturation-dependent susceptibility to monocyte-mediated cytotoxicity in acute myeloid leukemiaA A van de Loosdrecht, G J Ossenkoppele, R H Beelen, et al.
British Journal of Haematology|February 13, 2001
Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cellsY Xie, J P de Winter, Q Waisfisz, et al.
Pageof 16

Showing results (101-110 of 152) with videos related to

Sort By:
Pageof 16
Leukemia|April 15, 2003
A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemiaA van Stijn, A Kok, M A van der Pol, et al.
The Journal of Pathology|January 10, 2006
Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphomaJ J F Muris, C J L M Meijer, W Vos, et al.
European Journal of Haematology|January 1, 1991
Imipenem-cilastatin for empirical therapy in neutropenic patients with fever: an open study in patients with hematologic malignanciesP C Huijgens, G J Ossenkoppele, T F Weijers, et al.
Blood|December 1, 1994
Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localizationP C de Bruin, J A Kummer, P van der Valk, et al.
Leukemia Research|February 2, 2011
High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2M E D Chamuleau, G J Ossenkoppele, A van Rhenen, et al.
British Journal of Cancer|April 3, 1999
Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitorsS F Thijsen, G J Schuurhuis, J W van Oostveen, et al.
Haematologica|September 18, 2012
Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trialNigel Russell, Kenny Douglas, Anthony D Ho, et al.
Cell Death & Disease|June 27, 2014
IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survivalH Jmp Verhagen, D C de Leeuw, M Gm Roemer, et al.
Leukemia|August 1, 1994
Maturation-dependent susceptibility to monocyte-mediated cytotoxicity in acute myeloid leukemiaA A van de Loosdrecht, G J Ossenkoppele, R H Beelen, et al.
British Journal of Haematology|February 13, 2001
Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cellsY Xie, J P de Winter, Q Waisfisz, et al.
Pageof 16